Почетна › Akutna limfoblastna leukemija › Тексас
Kliničke studije za Akutna limfoblastna leukemija u državi Тексас
30 studija za Akutna limfoblastna leukemija traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
Zvanični tekst studije (na engleskom)
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Houston
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07109219A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Methodist Children's Hospital, San Antonio
Тражи се учесникФаза 1
Узраст од 0 до 18 · Оба пола · Ажурирано 13. 11. 2026. · NCT06173518TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- MD Anderson, Houston
- University of Texas Health Science Center San Antonio, San Antonio
Тражи се учесникФаза 1/2
До 1 година · Оба пола · Ажурирано 12. 11. 2026. · NCT05848687Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06308588Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT03263572Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069Personalized NK Cell Therapy in CBT
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст од 15 до 80 · Оба пола · Ажурирано 2. 11. 2026. · NCT02727803Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
Тражи се учесникОпсервациона студија
Узраст од 0 до 38 · Оба пола · Ажурирано 29. 10. 2026. · NCT06131801Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, Houston
Тражи се учесникФаза 1/2
Узраст 16 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07155226A Study of Revumenib and Mezigdomide in People With Leukemia
- MD Anderson Cancer Center (Data Collection Only), Houston
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07356154Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Тражи се учесникФаза 1
До 75 година · Оба пола · Ажурирано 2. 10. 2026. · NCT01853631A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст од 12 до 78 · Оба пола · Ажурирано 29. 9. 2026. · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- MD Anderson Cancer Center, Houston
- Sarah Cannon Transplant and Cellular Therapy Methodist Hospital, San Antonio
Тражи се учесникФаза 2
6 Months · Оба пола · Ажурирано 28. 9. 2026. · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Texas Children's Hospital, Houston
Тражи се учесникОпсервациона студија
4 Weeks – 18 Years · Оба пола · Ажурирано 24. 9. 2026. · NCT06529575First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- и још 10
Тражи се учесникФаза 1/2
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241A Study of CTD402 in T-ALL/LBL Patients
- MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1/2
Узраст 1 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT07070219Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- University of Texas, Southwestern, Dallas
- Baylor Texas Children's Hospital, Houston
Тражи се учесникФаза 2
Узраст од 7 до 25 · Оба пола · Ажурирано 19. 8. 2026. · NCT05082519Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Baylor College of Medicine Houston, Houston
- The University of Texas Health Science Center at San Antonio, San Antonio
Тражи се учесникОпсервациона студија
1 Day – 17 Years · Оба пола · Ажурирано 14. 8. 2026. · NCT06274788Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
- The University of Texas M. D. Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 8. 2026. · NCT07053059Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- M D Anderson Cancer Center, Houston
Тражи се учесникФаза 2
Узраст 15 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT03136146A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
- Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
- и још 5
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes
- University of Texas at Arlington Movement & Physical Activity Epidemiology Laboratory, Arlington
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 29. 5. 2026. · NCT06727942Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 18. 5. 2026. · NCT01790152Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 13 и старији · Оба пола · Ажурирано 5. 5. 2026. · NCT04771572A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1501, Houston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 4. 2026. · NCT06051409A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- MDACC, Houston
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 24. 3. 2026. · NCT04988555A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- MD Anderson, Houston
Тражи се учесникФаза 2
Узраст од 18 до 66 · Оба пола · Ажурирано 17. 3. 2026. · NCT06859424Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2025. · NCT04260022Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- University of Texas, Southwestern, Dallas
- Cook Children's Hospital, Fort Worth
- Texas Children's Hospital/Baylor College of Medicine, Houston
Тражи се учесникФаза 1
Узраст од 1 до 21 · Оба пола · Ажурирано 6. 12. 2024. · NCT05476770Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.